Autopsy report · NCT04784221

Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor Relapse

“Study prematurely terminated following the decision by industrial partner to withdraw from the project (product supply issue).”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Centre Francois Baclesse

Sponsor type

University, hospital or other

Conditions

Recurrent Cancer; Previous Radiation

Interventions

Radiation by protontherapy associated to nanoparticles injection

Participants

0

Trials that died the same way

• An Evaluation of a Novel Food Product in Adults Residing in an Area Endemic for Helminths
  “Due to a business decision to stop the project, the study was terminated early.” (82% match in meaning)
• Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses
  “Study was terminated due to a business decision to cancel the entire project.” (80% match in meaning)
• PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer
  “The study was terminated early due to company decision.” (78% match in meaning)
• Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
  “This study was terminated early due to company decision.” (77% match in meaning)
• A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers
  “Study terminated as part of strategic considerations” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.